DCM Shriram Industries has disclosed a significant shareholding change involving Urvashi Tilakdhar, a Person Acting in Concert (PAC) with the company's promoter group. The transaction represents a complete divestment of Tilakdhar's stake in the chemical and fertilizer manufacturer.

Transaction Details

The share sale involved a complete disposal of Tilakdhar's holdings in the company through an off-market transaction executed on March 30, 2026.

Pre and Post Transaction Holdings

The disclosure reveals the complete transformation of Tilakdhar's shareholding position in the company.

Company Capital Structure

DCM Shriram Industries' equity share capital remained unchanged following this transaction, maintaining its total at 86,992,185 shares. The company's shares are listed on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE).

Promoter Group Structure

The disclosure also provides insights into the broader promoter group holdings, with the Tilakdhar & Sons entity being part of a larger promoter consortium. The transaction was signed by Ashay Dhar representing Tilak Dhar & Sons, indicating the organized nature of the promoter group's shareholding structure.

Regulatory Compliance

This disclosure was made in compliance with Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates reporting of significant changes in shareholding patterns by promoters and persons acting in concert with them.

DCM Shriram Industries Ltd has announced a credit rating downgrade from CARE Edge Ratings across its bank facilities and fixed deposit programme. The rating agency communicated the revised ratings through letters dated 01.04.2026, following a comprehensive review of the company's operational and financial performance.

Rating Downgrades Across All Facilities

CARE Edge Ratings has downgraded multiple facilities of DCM Shriram Industries based on its performance review for Financial Year 2024-25 and the nine months period ended 31.12.2025. The rating agency also considered the impact of the Composite Scheme of Arrangement approved by the National Company Law Tribunal (NCLT).

Removal from Rating Watch

A significant development in the rating action is the removal of all facilities from Rating Watch with Negative implications. The long-term bank facilities and fixed deposit programme have been assigned a stable outlook, indicating that CARE Edge expects the ratings to remain steady in the near term despite the downgrades.

Regulatory Compliance

The company has disclosed this rating action in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information was communicated to both BSE Ltd and National Stock Exchange of India Ltd on April 2, 2026, ensuring transparency with stakeholders and regulatory authorities.

Corporate Governance

The disclosure was signed by Y.D. Gupta, Company Secretary and Compliance Officer, demonstrating the company's commitment to maintaining proper corporate governance standards. The rating review reflects CARE Edge's assessment of the company's creditworthiness following recent corporate restructuring activities and operational performance during the specified review periods.